Go to Content Go to Navigation Go to Navigation Go to Site Search Homepage

Planned Parenthood of Illinois Celebrates Protection of Abortion Pill

For Immediate Release: June 14, 2024 (Updated: June 13, 2024, 1:11 p.m.)


CHICAGO - Today, June 13,2024, the Supreme Court of the United States (SCOTUS) rejected the lawsuit FDA v Alliance for Hippocratic Medicine. This decision preserves access to the drug mifepristone, one of the two medications used in a medication abortion. 

The following statement is attributed to Jennifer Welch, President and CEO of Planned Parenthood

“Planned Parenthood of Illinois (PPIL) is pleased the Supreme Court rejected the lawsuit against the federal Food and Drug Administration’s (FDA) approval of mifepristone. We can and will continue offering the safe and effective two-medication regimen of mifepristone and misoprostol for abortion care. This is a win for PPIL patients and people across the country who can continue to access safe and legal medication abortion.

The FDA approved mifepristone more than 20 years ago, and it has since been used by more than five million people to safely end an early pregnancy. Medication abortion with mifepristone and misoprostol is the most common abortion procedure across the nation, which means PPIL patients can continue choosing their preferred method of care.   

While this is a temporary win for abortion rights, the battle is far from over. We will continue to fight and advocate for equitable access to all reproductive and sexual health care services, because everyone should have the ability to make a decision that is best for their bodies, their lives, and their futures.”

# # #

Planned Parenthood of Illinois (PPIL) provides affordable, high-quality reproductive health care services and medically accurate sexual health education to women, teens and men throughout Illinois. Through medical services, educational programs and advocacy efforts, PPIL works to ensure and protect the reproductive rights of each individual. For more information, visit www.ppil.org.

Media Contacts:

Mary Jane Maharry

[email protected]

773-490-6046

Celeste Sanchez

[email protected]

773-923-9906

Español

This website uses cookies

Planned Parenthood cares about your data privacy. We and our third-party vendors use cookies and other tools to collect, store, monitor, and analyze information about your interaction with our site to improve performance, analyze your use of our sites and assist in our marketing efforts. You may opt out of the use of these cookies and other tools at any time by visiting Cookie Settings. By clicking “Allow All Cookies” you consent to our collection and use of such data, and our Terms of Use. For more information, see our Privacy Notice.

Cookie Settings

Planned Parenthood cares about your data privacy. We and our third-party vendors, use cookies, pixels, and other tracking technologies to collect, store, monitor, and process certain information about you when you access and use our services, read our emails, or otherwise engage with us. The information collected might relate to you, your preferences, or your device. We use that information to make the site work, analyze performance and traffic on our website, to provide a more personalized web experience, and assist in our marketing efforts. We also share information with our social media, advertising, and analytics partners. You can change your default settings according to your preference. You cannot opt-out of required cookies when utilizing our site; this includes necessary cookies that help our site to function (such as remembering your cookie preference settings). For more information, please see our Privacy Notice.

Marketing

On

We use online advertising to promote our mission and help constituents find our services. Marketing pixels help us measure the success of our campaigns.

Performance

On

We use qualitative data, including session replay, to learn about your user experience and improve our products and services.

Analytics

On

We use web analytics to help us understand user engagement with our website, trends, and overall reach of our products.